100 related articles for article (PubMed ID: 8439663)
21. Effect of short-term pancreatico-biliary duct obstruction with intraductal hypertension on subcellular organelle fragility and pancreatic adenylate energy metabolism in rats: protective effect of a new protease inhibitor, E-3123.
Hirano T; Manabe T
Acta Chir Belg; 1994; 94(2):80-5. PubMed ID: 7517090
[TBL] [Abstract][Full Text] [Related]
22. Changes in both the membrane and the enzyme content of individual zymogen granules are associated with sodium taurocholate-induced pancreatitis in rats.
Manso MA; Orfao A; Tabernero MD; Vicente S; de Dios I
Clin Sci (Lond); 1998 Mar; 94(3):293-301. PubMed ID: 9616264
[TBL] [Abstract][Full Text] [Related]
23. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
[TBL] [Abstract][Full Text] [Related]
24. Effect of a new synthetic protease inhibitor on beta-endorphin release during acute pancreatitis in dogs.
Satake K; Hiura A; Ha SS; Nishiwaki H; Umeyama K
Pancreas; 1991 Jul; 6(4):441-7. PubMed ID: 1876600
[TBL] [Abstract][Full Text] [Related]
25. Aprotinin revisited: formulation, characterization, biodistribution and therapeutic potential of new aprotinin microemulsion in acute pancreatitis.
Karasulu HY; Oruç N; Üstündağ-Okur N; İlem Özdemir D; Ay Şenyiğit Z; Barbet Yılmaz F; Aşıkoğlu M; Özkılıç H; Akçiçek E; Güneri T; Özütemiz Ö
J Drug Target; 2015; 23(6):525-37. PubMed ID: 25738992
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
27. The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.
Satake K; Ha SS; Hiura A; Nishiwaki H
Gastroenterol Jpn; 1993 Feb; 28(1):64-71. PubMed ID: 8440425
[TBL] [Abstract][Full Text] [Related]
28. Distribution of a synthetic protease inhibitor in rat pancreatic acini after supramaximal secretagogue stimulation.
Otani T; Atomi Y; Kuroda A; Muto T; Tamura M; Fukuda S; Akao S; Gorelick FS
Pancreas; 1997 Mar; 14(2):142-9. PubMed ID: 9057186
[TBL] [Abstract][Full Text] [Related]
29. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
30. E-3123, a new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs.
Iwatsuki K; Horiuchi A; Yonekura H; Ren LM; Chiba S
Arch Int Pharmacodyn Ther; 1990; 308():168-77. PubMed ID: 1711836
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic regimens in acute experimental pancreatitis in rats: effects of a protease inhibitor, a beta-agonist, and antibiotics.
Araida T; Frey CF; Ruebner B; Carlson J; King J
Pancreas; 1995 Aug; 11(2):132-40. PubMed ID: 7479669
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice.
Makovec F; Bani M; Cereda R; Chistè R; Revel L; Rovati LC; Setnikar I; Rovati LA
Peptides; 1986; 7(6):1159-64. PubMed ID: 3104890
[TBL] [Abstract][Full Text] [Related]
33. Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.
Leonhardt U; Seidensticker F; Fussek M; Stöckmann F; Creutzfeldt W
Gut; 1990 Aug; 31(8):934-7. PubMed ID: 2387520
[TBL] [Abstract][Full Text] [Related]
34. The effect of a cholecystokinin receptor antagonist lorglumid on the proteinase-antiproteinase balance in taurocholate acute experimental pancreatitis (AEP) in rats.
Kosidło S; Rydzewska G; Gabryelewicz A
Mater Med Pol; 1992; 24(4):223-6. PubMed ID: 1308047
[TBL] [Abstract][Full Text] [Related]
35. Effect of a new synthetic trypsin inhibitor on taurocholate-induced acute pancreatitis in rats.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Pancreas; 1993 Mar; 8(2):240-7. PubMed ID: 8460097
[TBL] [Abstract][Full Text] [Related]
36. Phospholipase A2 in sodium taurocholate-induced experimental hemorrhagic pancreatitis in the rat.
Hietaranta AJ; Peuravuori HJ; Nevalainen TJ
J Surg Res; 1995 Aug; 59(2):271-8. PubMed ID: 7637343
[TBL] [Abstract][Full Text] [Related]
37. The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats.
Kim KH; Lee MG; Kim DG
Int J Pancreatol; 1996 Dec; 20(3):205-11. PubMed ID: 9013282
[TBL] [Abstract][Full Text] [Related]
38. Effects of pancreatic duct ligation and aging on acute taurocholate-induced pancreatitis. Experiments in the perfused pancreas in rats.
Kimura W; Okubo K; Han I; Kanai S; Matsushita A; Muto T; Miyasaka K
Int J Pancreatol; 1996 Apr; 19(2):117-27. PubMed ID: 8723554
[TBL] [Abstract][Full Text] [Related]
39. Effect of the oral administration of sepimostat mesilate on cerulein induced acute pancreatitis in rats.
Wang ZH; Manabe T; Ohshio G; Hirano T; Okada N; Imamura T; Kawaguchi Y; Yotsumoto F; Yamaki K; Imamura M
Arzneimittelforschung; 1995 Oct; 45(10):1082-6. PubMed ID: 8595064
[TBL] [Abstract][Full Text] [Related]
40. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat.
Hirano T; Manabe T
Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
